Hearing-aid use and its determinants in the UK National Health Service: A cross-sectional study at the Royal Surrey County Hospital

International Journal of Audiology

Volumn 54, Issue 3, 2015, Pages 152-161

  Aazh, Hashir ^a,b   Prasher, Deepak ^a   Nanchahal, Kiran ^b   Moore, Brian C J ^c  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Hearing aids; Hearing aid use; Satisfaction; Survey

Indexed keywords

ADOLESCENT; ADULT; AGED; AUDITORY REHABILITATION; CROSS-SECTIONAL STUDY; FEMALE; HEARING AID; HUMAN; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROCEDURES; PSYCHOLOGY; PUBLIC HEALTH; PUBLIC HOSPITAL; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CORRECTION OF HEARING IMPAIRMENT; CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; HEARING AIDS; HOSPITALS, COUNTY; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PATIENT COMPLIANCE; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84923910754     PISSN: 14992027     EISSN: 17088186     Source Type: Journal    
DOI: 10.3109/14992027.2014.967367     Document Type: Article

References (29)

1. Edersheim JG. Off-label Prescribing. Prescribing Times. Available from: Available from: http://www.psychiatrictimes.com/articles/label-prescribing#sthash.a9MTKKtC.dpuf. [Last accessed on 2014 Feb 21].
2. Stafford RS. Regulating off-label drug use - Rethinking the role of the FDA. N Engl J Med 2008;358:1427-9.
3. Healy D, Nutt D. Prescriptions, licence and evidence. Psychiatr Bull 1998;22:680-4.
4. Murashev N. WARNING: Think Twice Before Filling Your Antidepressant Presciption; 2012. Available from: http://www.psychworld.com/think-before-filling-antidepressent-prescription-2010-03. [Last accessed on 2014 Feb 21].
5. Ilyas S, Moncrieff J. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. Br J Psychiatry 2012;200:393-8.
6. Baldwin D, Kosky N. Off-label prescribing in psychiatric practice. Adv Psychiatr Treat 2007;13:414-22.
7. Haw C, Stubbs J. Benzodiazepines - A necessary evil? A survey of prescribing at a specialist UK psychiatric hospital. J Psychopharmacol 2007;21:645-9.
8. Leslie DL, Mohamed S, Rosenheck RA. Off-label use of antipsychotic medications in the department of Veterans Affairs health care system. Psychiatr Serv 2009;60:1175-81.
9. Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med 2006;166:1021-6.
10. Douglas-Hall P, Fuller A, Gill-Banham S. An analysis of off-licence prescribing in psychiatric medicine. Pharm J 2001;267:890-1.
11. Lowe-Ponsford F, Baldwin, D. Off-label prescribing by psychiatrists. Psychol Bull 2000;24:415-7.
12. Maher AR, Theodore G. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. J Manag Care Pharm 2012;18 5 Suppl B: S1-20.
13. Kmietowicz Z. Eli Lilly pays record $1.4bn for promoting off-label use of olanzapine. BMJ 2009;338:b217.
14. Tanne JH. AstraZeneca pays $520m fine for off label marketing. BMJ 2010;340:c2380.
15. Devulapalli KK, Nasrallah HA. An analysis of the high psychotropic off-label use in psychiatric disorders The majority of psychiatric diagnoses have no approved drug. Asian J Psychiatr 2009;2:29-36.
16. Chouinard G. The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs. J Psychiatry Neurosci 2006;31:168-76.
17. st ed. London: Pharmaceutical Press, Royal Pharmaceutical Society; 2011.
18. Thakkar KB, Jain MM, Billa G, Joshi A, Khobragade AA. A drug utilization study of psychotropic drugs prescribed in the Psychiatry Outpatient Department of a Tertiary Care Hospital. J Clin Diagn Res 2013;7:2759-64.
19. Piparva KG, Parmar DM, Singh AP, Gajera MV, Trivedi HR. Drug utilization study of psychotropic drugs in outdoor patients in a teaching hospital. Indian J Psychol Med 2011;33:54-8.
20. Lahon K, Shetty H, Paramel A, Sharma G. A retrospective drug utilization study of antidepressants in the psychiatric unit of a tertiary care hospital. J Clin Diagn Res 2011;5:1069-75.
21. Hodgson R, Belgamar R. Off-label prescribing by psychiatrists. Psychiatr Bull 2006;30:55-7.
22. Barbui C, Danese A, Guaiana G, Mapelli L, Miele L, Monzani E, et al. Prescribing second-generation antipsychotics and the evolving standard of care in Italy. Pharmacopsychiatry 2002;35:239-43.
23. Maglione M, Maher AR, Hu J, Wang Z, Shanman R, Shekelle PG, et al. Off-Label Use of Atypical Antipsychotics: An Update. AHRQ Comparative Effectiveness Reviews. Agency for Healthcare Research and Quality (US); 2011 Sep. Report No.: 11-EHC087-EF.
24. Morishita S. Clonazepam as a therapeutic adjunct to improve the management of depression: A brief review. Hum Psychopharmacol 2009;24:191-8.
25. Barbui C, Cipriani A, Patel V, Ayuso-Mateos JL, van Ommeren M. Efficacy of antidepressants and benzodiazepines in minor depression: Systematic review and meta-analysis. Br J Psychiatry 2011;198:11-6.
26. Ananthavarathan P. A Systematic review and meta-analysis of the efficacy and safety of sodium valproate for "off-label" indications in mental health. J Neurol Neurosurg Psychiatry 2014;85:8e3.
27. Dold M, Li C, Gillies D, Leucht S. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and Cochrane review of randomized controlled trials. Eur Neuropsychopharmacol 2013;23:1023-33.
28. Stahl SM. Essential Psychopharma Stahlogy-prescribing Off-label in Psychopharmacology. Is it the Exception or the Rule. United Kingdom: Cambridge University Press; 2005.
29. DRUGDEX® System. Greenwood Village, CO: Thomson Micromedex. Updated periodically. Available from: http://micromedex.com/. [Last accessed on 2014 Feb 21].